Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China

Lundbeck's Vyepti (eptinezumab) receives South Korean approval for preventive treatment of migraine

Eli Lilly reports positive Phase 1b results for VERVE-102

Pierre Fabre Laboratories' BRAFTOVI (encorafenib) combination receives CHMP positive opinion in BRAFV600E-mutant mCRC

Dicot Pharma submits FDA application for LIB-01 phase 2b study

European Commission approves Pharming's Joenja for APDS treatment in the EU

Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514

AbbVie's MAVIRET receives positive opinion from European regulator

Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours

Allergan Aesthetics reports positive CHMP opinion recommending approval of Boey (trenibotulinumtoxinE)

Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment

Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio

Implantica submits final FDA response for RefluxStop PMA application